Homeground | |||||||||||||||||
| wonderful | |||||||||||||||||
|
|
While the ethica concerns raise about availbility , clinical trails, release of GMO �s for m the manufactue process, possible loongterm harmful esafety of fects etc, are paramount to an bioethical and the ethcis of public health to evaluation of the new and existing technologies, it is important to notice also the implication and values underlying the exitement curent chift form one technology to another. This change of R&D focus and prorites cannot escape ethical scruteny. By its very nature any ethical evaluation cannot isolate singular lements of a process and avoid the context of the developmet under assesment. The crucial question is wheter indeed there is a a discrepence between the intresst of the healt of a given population and the economic intreat of the major playest in the pharmaceutical industry. Secondly how can we ensure that we strkile an fruitfull balance between the ecomomic insenticve and the adequeate provision of vaccines. The object here is not to suggest way of regulation the industry, rather it is a matter of considering the extnet to whice there is a moral obloigation upon scientists as individuals and coorporate enterpriss to consider the coparative value of their research To other public health interventions. Selfintrest and as part of this , economic intrest , is undoubetly an motication factor behind. It would be a crime to restrict the scietific | ||||||||||||||||
|
|
While the ethica concerns raise about availbility , clinical trails, release of GMO �s for m the manufactue process, possible loongterm harmful esafety of fects etc, are paramount to an bioethical and the ethcis of public health to evaluation of the new and existing technologies, it is important to notice also the implication and values underlying the exitement curent chift form one technology to another. This change of R&D focus and prorites cannot escape ethical scruteny. By its very nature any ethical evaluation cannot isolate singular lements of a process and avoid the context of the developmet under assesment. The crucial question is wheter indeed there is a a discrepence between the intresst of the healt of a given population and the economic intreat of the major playest in the pharmaceutical industry. Secondly how can we ensure that we strkile an fruitfull balance between the ecomomic insenticve and the adequeate provision of vaccines. The object here is not to suggest way of regulation the industry, rather it is a matter of considering the extnet to whice there is a moral obloigation upon scientists as individuals and coorporate enterpriss to consider the coparative value of their research To other public health interventions. Selfintrest and as part of this , economic intrest , is undoubetly an motication factor behind. It would be a crime to restrict the scietific | ||||||||||||||||
|
| |||||||||||||||||
| |||||||||||||||||
|
This page has been visited
|